{"nct_id":"NCT02362594","title":"Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2015-07-16","start_date_type":"ACTUAL","primary_completion_date":"2018-01-08","primary_completion_date_type":"ACTUAL","completion_date":"2026-11-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}